-

KBRA Releases Monthly CMBS Trend Watch

NEW YORK--(BUSINESS WIRE)--KBRA releases the January 2025 issue of CMBS Trend Watch.

Following on the heels of a strong 2024 issuance year, January continued to exhibit strength, with year-over-year (YoY) private label CMBS issuance increasing 38.1%. This was despite the benchmark rate increasing, while credit spreads remained stable relative to year-end. Commercial real estate collateralized loan obligations (CRE CLO) issuance was also very active in January, already reaching approximately one-half of full-year 2024 volume in the month. Despite the possible volatility that the current administration’s policy shifts may bring, February should also bring solid gains based on our current visibility, as there could be up to 21 rated deals including nine single borrower (SB), seven conduits, three CRE CLO, and two Freddie Mac (Agency).

In January, KBRA published pre-sales for six deals including two conduits ($1.8 billion), two SB ($1.7 billion), one re-remic ($3.5 billion), and one CRE CLO ($984 million). January’s surveillance activity included rating reviews of 420 securities issued in connection with 50 transactions. Of the 420 ratings, 340 were affirmed, 56 were downgraded, and 24 were upgraded. In addition, eight ratings were maintained on Watch Developing based on one deal.

This month’s edition also highlights recent KBRA research publications that cover various topical issues.

Click here to view the report.

Recent Publications

About KBRA

KBRA, one of the major credit rating agencies, is registered in the U.S., EU, and the UK. KBRA is recognized as a Qualified Rating Agency in Taiwan, and is also a Designated Rating Organization for structured finance ratings in Canada. As a full-service credit rating agency, investors can use KBRA ratings for regulatory capital purposes in multiple jurisdictions.

Doc ID: 1007884

Contacts

Solomon Mankin, Senior Analyst
+1 646-731-1244
solomon.mankin@kbra.com

Aryansh Agrawal, Senior Analyst
+1 646-731-1381
aryansh.agrawal@kbra.com

Larry Kay, Senior Director
+1 646-731-2452
larry.kay@kbra.com

Business Development Contact

Andrew Foster, Director
+1 646-731-1470
andrew.foster@kbra.com

Kroll Bond Rating Agency, LLC

Details
Headquarters: New York City, New York
CEO: Jim Nadler
Employees: 400+
Organization: PRI

Release Versions

Contacts

Solomon Mankin, Senior Analyst
+1 646-731-1244
solomon.mankin@kbra.com

Aryansh Agrawal, Senior Analyst
+1 646-731-1381
aryansh.agrawal@kbra.com

Larry Kay, Senior Director
+1 646-731-2452
larry.kay@kbra.com

Business Development Contact

Andrew Foster, Director
+1 646-731-1470
andrew.foster@kbra.com

Social Media Profiles
More News From Kroll Bond Rating Agency, LLC

KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2)

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 71 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2). The transaction consists of 1,118 investment property mortgages with an aggregate principal balance of $438.4 million as of the March 1, 2026 cut-off date. The collateral is characterized by a weighted average (WA) original credit score of 770 and moderate borrower equity, with a WA original LTV and WA original CLTV of 73.2%. KBR...

KBRA Assigns Preliminary Ratings to Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to six classes of notes issued by Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1 (collectively “RPM 2026-R1”), an auto loan ABS transaction. RPM 2026-R1 has initial credit enhancement levels of 35.69% for the Class A notes to 2.65% for the Class E-2 notes. Credit enhancement is comprised of overcollateralization, subordination of junior note classes (except for the Class E-2 notes), a ca...

KBRA Releases Research – What’s up, Doc – Medical Professional Mortgages, A New Niche in RMBS?

NEW YORK--(BUSINESS WIRE)--KBRA releases research assessing the characteristics of medical professional mortgage (MPM) loans, with a focus on their potential role as a niche collateral segment within the prime private label residential mortgage-backed securities (RMBS) market. MPMs, often called physician or doctor loans, are specialized prime mortgage programs designed for medical professionals whose early-career financial profiles often include high student debt, limited savings, and reliance...
Back to Newsroom